Experts see Nifty reaching 25,000, picks Emami, Bharti Airtel, Concord Biotech

The Nifty 50 has shown remarkable resilience, closing above 24,100 on Friday, November 29. This marks a recovery of over 1,000 points from its lows, with strong support from the 200-day Exponential Moving Averages (EMA) across major indices. The index has broken out of a falling channel, and both the daily and weekly RSI (Relative Strength Index) indicate that more upside is likely. An Inverse Head-and-Shoulders pattern is emerging, and if the Nifty crosses 24,350, it could rally toward 25,000.

Meanwhile, Bank Nifty has been trading sideways within the 51,750-52,750 range after a gap-up on November 25. The key support lies at 51,750, and resistance is near 52,750. A breakdown could push the index to 51,300, while a breakout above 52,750 could lead to a rally toward 53,000, signaling sustained bullish momentum.

Nifty Futures Strategy:

Buy Nifty Futures: Enter between 24,200-24,225

Stop-Loss: 24,050

Target: 24,500

Bank Nifty Futures Strategy:

Buy Bank Nifty Futures: Enter with a stop-loss of 52,200-52,250

Stop-Loss: 51,800

Target: 53,000

Top 3 Stock Picks for Short-Term Investments

Emami

CMP: Rs 684

Emami has shown bullish technical signals, having formed a base near the 200-day EMA. The stock recently broke out of a bearish trendline, signaling the alleviation of downward pressure. A bullish RSI divergence further supports the move upward. Traders should buy within the range of Rs 675-685, with a target of Rs 750 and a stop-loss at Rs 645.

Strategy: Buy

Target: Rs 750

Stop-Loss: Rs 645

Bharti Airtel

CMP: Rs 1,627

Bharti Airtel has demonstrated strong momentum by surpassing its previous swing high and closing above it. The stock found support at the 20-day EMA and has broken above the R4 level of the Camarilla Pivot, signaling continued upward movement. The RSI on both the daily and weekly charts further confirms the bullish trend. Buy in the range of Rs 1,600-1,630, targeting Rs 1,775 with a stop-loss at Rs 1,535.

Strategy: Buy

Target: Rs 1,775

Stop-Loss: Rs 1,535

Concord Biotech

CMP: Rs 2,127.5

Concord Biotech broke out of a four-day consolidation phase and closed significantly above the R4 level of the Camarilla Pivot, indicating strong buying interest. A trendline breakout on the weekly chart further supports the bullish case. Traders should enter between Rs 2,100-2,130, with a target of Rs 2,300 and a stop-loss below Rs 2,050.

Strategy: Buy

Target: Rs 2,300

Stop-Loss: Rs 2,050

Disclaimer: The views and investment tips expressed by experts are their own. Always consult certified professionals before making any investment decisions.